when will semaglutide become generic injectable could cost as little as $28 per person-year after the initial patent expired in April 2026 — a fraction of current branded prices — and be available in about Off-patent semaglutide in 2026: the

Wegovy: Specifically approved for chronic weight management in adults with a BMI of 30 kg/m, or 27 kg/m with weight-related medical diseases/conditions

The strength of the doses is increased gradually to help manage the common side effects that most people experience as their body gets accustomed to the medication

100

Weight management concerns should be discussed with a qualified healthcare professional before starting any prescription program

The duration of the nasal tan sprays effects in your system can vary depending on factors such as your individual metabolism, the dosage, and frequency of use

1 (25 ml) , 30